IRIS
BENFAREMO, Devis
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.767
EU - Europa 1.793
AS - Asia 1.653
SA - Sud America 334
AF - Africa 139
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 7.690
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.688
IT - Italia 573
SG - Singapore 548
VN - Vietnam 356
RU - Federazione Russa 303
CN - Cina 299
BR - Brasile 251
HK - Hong Kong 148
DE - Germania 131
IE - Irlanda 131
UA - Ucraina 126
SE - Svezia 118
FR - Francia 111
GB - Regno Unito 84
IN - India 62
CI - Costa d'Avorio 60
FI - Finlandia 54
BD - Bangladesh 52
CA - Canada 35
NL - Olanda 32
DK - Danimarca 31
TR - Turchia 31
MX - Messico 29
MA - Marocco 27
AR - Argentina 26
JP - Giappone 26
PL - Polonia 25
AT - Austria 22
KR - Corea 22
IQ - Iraq 19
ZA - Sudafrica 19
CO - Colombia 16
TW - Taiwan 12
BE - Belgio 11
EC - Ecuador 11
ES - Italia 9
PH - Filippine 9
UZ - Uzbekistan 9
VE - Venezuela 9
LT - Lituania 8
SA - Arabia Saudita 8
TN - Tunisia 8
ID - Indonesia 7
CL - Cile 6
EG - Egitto 6
IL - Israele 6
KE - Kenya 6
OM - Oman 6
CH - Svizzera 5
GR - Grecia 5
PK - Pakistan 5
PY - Paraguay 5
JM - Giamaica 4
JO - Giordania 4
MY - Malesia 4
NI - Nicaragua 4
UY - Uruguay 4
AL - Albania 3
AZ - Azerbaigian 3
BO - Bolivia 3
DZ - Algeria 3
ET - Etiopia 3
PE - Perù 3
AE - Emirati Arabi Uniti 2
AU - Australia 2
HR - Croazia 2
KH - Cambogia 2
KZ - Kazakistan 2
NP - Nepal 2
PA - Panama 2
PS - Palestinian Territory 2
PT - Portogallo 2
QA - Qatar 2
TT - Trinidad e Tobago 2
AO - Angola 1
CG - Congo 1
CR - Costa Rica 1
CY - Cipro 1
DM - Dominica 1
EE - Estonia 1
EU - Europa 1
HN - Honduras 1
HU - Ungheria 1
IR - Iran 1
LV - Lettonia 1
MM - Myanmar 1
MT - Malta 1
MU - Mauritius 1
NA - Namibia 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
RO - Romania 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
ZW - Zimbabwe 1
Totale 7.690
Salva come PNG Salva come JPEG
Città #
Ashburn 755
Singapore 343
Chandler 330
Dallas 200
San Jose 189
Fairfield 173
Hong Kong 144
Jacksonville 139
Dublin 129
Des Moines 120
Ho Chi Minh City 120
New York 115
Boardman 90
Hanoi 86
Wilmington 84
Woodbridge 82
Los Angeles 81
Beijing 77
Seattle 77
Houston 74
Ancona 66
Centro 63
Lauterbourg 62
The Dalles 62
Abidjan 60
Moscow 60
Munich 51
Lawrence 49
Princeton 49
Ann Arbor 46
Milan 45
Cambridge 44
Council Bluffs 41
Redmond 40
Orem 33
San Mateo 33
São Paulo 30
Buffalo 29
Rome 27
Haiphong 25
Turin 25
San Diego 24
Helsinki 23
Tolentino 23
Chicago 22
London 22
Santa Clara 22
Warsaw 22
Washington 20
Hefei 19
Chennai 18
Frankfurt am Main 18
Turku 18
Brooklyn 17
Montreal 17
Johannesburg 14
Tokyo 14
Poplar 13
Atlanta 12
Da Nang 12
Pune 12
Denver 11
Boston 10
Brussels 10
Columbus 10
Manchester 10
Nuremberg 10
Amsterdam 9
Iesi 9
Marche 9
San Francisco 9
Tashkent 9
Baghdad 8
Brasília 8
Cagliari 8
Guangzhou 8
Mexico City 8
Monte San Pietrangeli 8
Mumbai 8
Norwalk 8
Vienna 8
Wuhan 8
Belo Horizonte 7
Miano 7
Phoenix 7
Shanghai 7
Stockholm 7
Amandola 6
Bắc Ninh 6
Charlotte 6
Medellín 6
Querétaro 6
West Jordan 6
Aversa 5
Biên Hòa 5
Comunanza 5
Dhaka 5
Goiânia 5
Guayaquil 5
Hangzhou 5
Totale 5.002
Salva come PNG Salva come JPEG
Nome #
Abnormal liver function tests predict transfer to intensive care unit and death in COVID-19 192
Gut epithelial impairment, microbial translocation and immune system activation in inflammatory bowel disease–associated spondyloarthritis 186
ACCURACY OF DUAL-ENERGY COMPUTED TOMOGRAPHY FOR THE DETECTION OF BONE MARROW EDEMA IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS 183
Increased expression of the ectoenzyme CD38 in peripheral blood plasmablasts and plasma cells of patients with systemic sclerosis 181
Clinical and patient reported outcomes of the multidisciplinary management in patients with inflammatory bowel disease-associated spondyloarthritis 176
Multicenter validation of the DETAIL questionnaire for the screening of spondyloarthritis in patients with inflammatory bowel diseases 170
Clinical outcomes and feasibility of the multidisciplinary management of patients with psoriatic arthritis: two-year clinical experience of a dermo-rheumatologic clinic 167
Adalimumab efficacy in enteropathic spondyloarthritis: A 12-mo observational multidisciplinary study 166
SARS-COV-2 Infection, Vaccination, and Immune-Mediated Diseases: Results of a Single-Center Retrospective Study 163
6 and 12 month outcomes in patients following COVID-19-related hospitalization: a prospective monocentric study 159
Biomarkers in Inflammatory Bowel Disease-Associated Spondyloarthritis: State of the Art and Unmet Needs 153
Effect of Adalimumab Therapy on Both Gastrointestinal and Articular Inflammation at 6 Months in Patients Affected by Enteropathic Spondyloarthritis: Preliminary Results from a Monocentric Prospective Observational Study 151
Sclerostin and Antisclerostin Antibody Serum Levels Predict the Presence of Axial Spondyloarthritis in Patients with Inflammatory Bowel Disease 149
The DETection of Arthritis in Inflammatory boweL diseases (DETAIL) questionnaire: development and preliminary testing of a new tool to screen patients with inflammatory bowel disease for the presence of spondyloarthritis 147
Disease course in patients with systemic autoimmune diseases: insights on the safety of immunosuppression during the SARS-CoV-2 outbreak in Italy 145
The ATTRACT study: screening for the early identification of axial psoriatic arthritis in a cohort of Italian psoriatic patients 143
A validation study of the Simple Psoriatic Arthritis Screening (SiPAS) questionnaire to screen psoriasis patients for psoriatic arthritis 142
Diagnosis and management of leukocytoclastic vasculitis 140
Certolizumab pegol for the treatment of psoriasis 139
Subcutaneous immunoglobulin in inflammatory myopathies: efficacy in different organ systems 138
Patient Reported Outcomes and Quality of Life in a Cohort of Patients Affected by Entheropathic Spondyloarthritis: Preliminary Results from a Monocentric Prospective Observational Study 137
Biologics in inflammatory immune-mediated systemic diseases 133
A painful diagnosis 133
Systemic Sclerosis: From Pathophysiology to Novel Therapeutic Approaches 131
Videofluorography swallow study in patients with systemic sclerosis: correlation with clinical and radiological features 127
Aseptic inflammation of prosthetic knee in a patient affected by rheumatoid arthritis 126
Dual-energy computed tomography for the detection of sacroiliac joints bone marrow oedema in patients with axial spondyloarthritis 125
Mycophenolate mofetil-induced colitis in a patient with systemic sclerosis 125
PDGF/PDGFR: A Possible Molecular Target in Scleroderma Fibrosis 124
MULTICENTER VALIDATION OF THE DETECTION OF ARTHRITIS IN INFLAMMATORY BOWEL DISEASES (DETAIL) QUESTIONNAIRE FOR THE SCREENING OF SPONDYLOARTHRITIS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES 123
Increased expression of the ectoenzyme CD38 in peripheral blood plasmablasts and plasma cells of patients with systemic sclerosis 122
Chronic hepatitis E in a patient treated with rituximab and mycophenolate mofetil for Sjögren's syndrome 121
Putative functional pathogenic autoantibodies in systemic sclerosis 117
Hydroxychloroquine, dermatology, and SARS-CoV-2: Updating an old association 117
Adeno-associated virus type 5 infection via PDGFRα is associated with Interstitial lung disease in systemic sclerosis and generates composite peptides and epitopes recognized by the agonistic immunoglobulins present in patients with systemic sclerosis 116
Patient reported outcomes and assessment of the quality of life in a cohort of patients affected by enteropathic spondyloarthritis: results of a monocentric prospective observational study at one year 113
Biologics in inflammatory and immunomediated arthritis 111
A young man with persistent dyspepsia: The unexpected virtue of proton-pump inhibitors 106
Musculoskeletal and rheumatic diseases induced by immune checkpoint inhibitors: A review of the literature 100
Upadacitinib effectiveness and factors associated with minimal disease activity achievement in patients with psoriatic arthritis: preliminary data of a real-life multicenter study 98
Efficacy and safety of intravenous and subcutaneous tocilizumab in a cohort of patients affected by rheumatoid arthritis in real-life 97
Skin Gene Expression Profiles in Systemic Sclerosis: From Clinical Stratification to Precision Medicine 96
New Insights in Physical Therapy and Rehabilitation in Psoriatic Arthritis: A Review 95
Axial psoriatic arthritis in patients not fulfilling the back pain entry features of the ASAS Classification Criteria for Axial Spondyloarthritis: findings from the ATTRACT Study 94
Dolore Articolare Acuto 94
Current take on systemic sclerosis patients’ vaccination recommendations 93
The neuropathic pain features in Psoriatic Arthritis: a cross-sectional evaluation of prevalence and associated factors 91
Atypical Spontaneous Hematomas in a Patient with Severe Coronavirus Disease 2019 (COVID-19) 86
Discharge from the emergency department and early hospital revaluation in patients with COVID-19 pneumonia: a prospective study 86
Statins, ACE/ARBs drug use, and risk of pneumonia in hospitalized older patients: a retrospective cohort study 86
Hypogammaglobulinemia in patients affected by limited cutaneous systemic sclerosis: Case series and review of the literature 83
Speckle-tracking global longitudinal strain predicts death and cardiovascular events in patients with systemic sclerosis 83
Novel therapeutic approaches and treatment targets for psoriatic arthritis 82
Safety of intermediate dose of low molecular weight heparin in COVID-19 patients 81
Screening and Analysis of Possible Drugs Binding to PDGFRα: A Molecular Modeling Study 79
Antihypertensive treatment changes and related clinical outcomes in older hospitalized patients 79
Pre-scleroderma and new opportunities for preventive medicine 78
Real-life efficacy and safety of nintedanib in systemic sclerosis-interstitial lung disease: data from an Italian multicentre study 78
Widespread painful nodules in a patient with rheumatoid arthritis 78
Atypical neutrophilic panniculitis as presentation of BCR-ABL1-negative chronic myeloid leukaemia 78
Enteropathic spondyloarthritis: Results from a large nationwide database analysis 77
Role of cognitive impairment and malnutrition as determinants of quality of life in patients with systemic sclerosis 75
Is there a future for anti-cd38 antibody therapy in systemic autoimmune diseases? 71
Tocilizumab for severe COVID-19 pneumonia 69
Inflammatory bowel disease manifestations in spondyloarthritis: considerations for the clinician 68
Skin ultrasound in systemic sclerosis: past, present and exciting future 59
Systemic Sclerosis: A Key Model of Endothelial Dysfunction 58
Prescription of ACE-Is/ARBs in patients with cardio-renal disease: a multicenter retrospective cohort study from the REPOSI registry 49
Doppler ultrasound, a noninvasive tool for the study of mesenteric arterial flow in systemic sclerosis: a cross-sectional study of a patient cohort with review and meta-analysis of the literature 48
null 24
Micro- and Macro-Vascular Disease in Systemic Sclerosis and Very Early SSc (VEDOSS): Results from a Monocentric Observational Study 15
The role of integrated gastro-rheumatological care in IBD-associated Spondyloarthritis in achieving joint-gut remission: Four-year outcomes from the real-world SPIB cohort 3
Safety and effectiveness of tocilizumab in systemic sclerosis: a multicentre French-Italian study 3
Expert Perspectives: Defining and managing progressive pulmonary fibrosis in systemic sclerosis 1
Totale 7.932
Salva come PNG Salva come JPEG
Categoria #
all - tutte 37.490
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.490
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202145 0 0 0 0 0 0 0 0 0 0 0 45
2021/2022380 23 41 22 6 9 40 6 14 32 36 78 73
2022/2023898 68 103 67 79 44 201 11 53 187 10 59 16
2023/2024622 70 14 51 63 86 139 25 26 9 80 14 45
2024/20251.288 177 91 20 32 68 60 170 58 216 70 149 177
2025/20263.593 287 207 198 335 438 245 579 359 299 332 155 159
Totale 7.932